Literature DB >> 5879214

Hashish. I. The structure of cannabidiol.

R Mechoulam, Y Shvo.   

Abstract

Entities:  

Mesh：

Year:  1963        PMID： 5879214     DOI： 10.1016/0040-4020(63)85022-x

Source DB:  PubMed          Journal:  Tetrahedron        ISSN： 0040-4020            Impact factor:   2.457


× No keyword cloud information.
  91 in total

1.  Cannabinoids in the Treatment of Neurological Disorders.

Authors:  Orrin Devinsky; Benjamin J Whalley; Vincenzo Di Marzo
Journal:  Neurotherapeutics       Date:  2015-10       Impact factor: 7.620

2.  Cannabinoid Inheritance Relies on Complex Genetic Architecture.

Authors:  Lesley G Campbell; Jaimie Dufresne; Sarah A Sabatinos
Journal:  Cannabis Cannabinoid Res       Date:  2020-02-27

Review 3.  Cannabidiol regulation of emotion and emotional memory processing: relevance for treating anxiety-related and substance abuse disorders.

Authors:  Jonathan L C Lee; Leandro J Bertoglio; Francisco S Guimarães; Carl W Stevenson
Journal:  Br J Pharmacol       Date:  2017-03-09       Impact factor: 8.739

4.  Cannabis 25 (1), biotransformation of cannabidiol and cannabidiolic acid by Pinellia ternata tissue segments.

Authors:  H Tanaka; R Takahashi; S Morimoto; Y Shoyama
Journal:  Plant Cell Rep       Date:  1996-08       Impact factor: 4.570

5.  Cannabis, a complex plant: different compounds and different effects on individuals.

Authors:  Zerrin Atakan
Journal:  Ther Adv Psychopharmacol       Date:  2012-12

Review 6.  Cannabidiol: pharmacology and potential therapeutic role in epilepsy and other neuropsychiatric disorders.

Authors:  Orrin Devinsky; Maria Roberta Cilio; Helen Cross; Javier Fernandez-Ruiz; Jacqueline French; Charlotte Hill; Russell Katz; Vincenzo Di Marzo; Didier Jutras-Aswad; William George Notcutt; Jose Martinez-Orgado; Philip J Robson; Brian G Rohrback; Elizabeth Thiele; Benjamin Whalley; Daniel Friedman
Journal:  Epilepsia       Date:  2014-05-22       Impact factor: 5.864

7.  Molecular targets for cannabidiol and its synthetic analogues: effect on vanilloid VR1 receptors and on the cellular uptake and enzymatic hydrolysis of anandamide.

Authors:  T Bisogno; L Hanus; L De Petrocellis; S Tchilibon; D E Ponde; I Brandi; A S Moriello; J B Davis; R Mechoulam; V Di Marzo
Journal:  Br J Pharmacol       Date:  2001-10       Impact factor: 8.739

Review 8.  Treatment studies with cannabinoids in anorexia nervosa: a systematic review.

Authors:  Emilie Vangsgaard Rosager; Christian Møller; Magnus Sjögren
Journal:  Eat Weight Disord       Date:  2020-04-02       Impact factor: 4.652

9.  Cannabidiol displays antiepileptiform and antiseizure properties in vitro and in vivo.

Authors:  Nicholas A Jones; Andrew J Hill; Imogen Smith; Sarah A Bevan; Claire M Williams; Benjamin J Whalley; Gary J Stephens
Journal:  J Pharmacol Exp Ther       Date:  2009-11-11       Impact factor: 4.030

Review 10.  Cannabinoids and Epilepsy.

Authors:  Evan C Rosenberg; Richard W Tsien; Benjamin J Whalley; Orrin Devinsky
Journal:  Neurotherapeutics       Date:  2015-10       Impact factor: 7.620
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.